Knockdown of phosphoglycerate mutase 1 (PGAM1) could reconstruct the expression of ASS1 in breast cancer (BC) cells, resulting in a decrease in tumor growth and exerting antitumor effects via cAMP/AMPK/CEBPB axis. The gene discussed is CEBPB; the disease is breast cancer.